Jump to content
Health NZ Taranaki Lab Manual

Tests:CA 15-3: Difference between revisions

Department
Biochemistry
Tests:CA 15-3
No edit summary
No edit summary
Line 20: Line 20:
CA153
CA153
|-
|-
|Test Availability
|Availability
|Tuesdays and Friday
|Tuesdays and Friday
Contact the laboratory if testing required urgently. 
Contact the laboratory if testing required urgently. 
Line 33: Line 33:
== Specimen Requirements ==
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Plasma
|Plasma
Serum
Serum
|-
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
Line 47: Line 44:
|-
|-
|Unacceptable
|Unacceptable
|
|-
|Specimen Transportation
|
|
|-
|-
Line 55: Line 55:
== Aliquot Requirements ==
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample  
|Serum
|Serum
|-
|-

Revision as of 13:17, 20 March 2025


Overview

Department Biochemistry 
Test Code CA153
Synonyms C153

C15-3

CA153

Availability Tuesdays and Friday

Contact the laboratory if testing required urgently. 

Turnaround Time 1 – 4 days 
Stability – Add test

Specimen Requirements

Specimen Plasma

Serum

Preferred 7mL Red-Top
Acceptable SST Yellow-Top
Unacceptable
Specimen Transportation
Paediatric Requirements 0.5 Red microtainer  

Aliquot Requirements

Sample Serum
Preferred Volume >500 uL
Minimum Volume 200 uL
Aliquot Transportation Samples should be separated from red cells within 24hrs of collection. 

Clinical Information

Reference Intervals <30 U/mL 
Test Method Abbott Architect analyser using Abbott reagents.  

CMIA method

Advanced Notice
Patient Preparation

Comments

Ca 15-3 is particularly useful for monitoring breast cancer.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.